Skip to main content

Table 4 Primary and secondary outcomes in enrolled infants–per-protocol analysis

From: Simplified antibiotic regimens for treating neonates and young infants with severe infections in the Democratic Republic of Congo: a comparative efficacy trial

Regimena

A

B

C

D

Number of infants analyzed

146

135

144

135

Treatment failure n (%)

17 (11.6%)

13 (9.6%)

13 (9.0%)

9 (6.7%)

 Risk difference % (95% CI)

referent

-2.0 (− 9.2 to 5.2)

-2.6 (−9.6 to 4.4)

-5.0 (−11.7 to 1.7)

Reason for treatment failure

 Death

1 (0.7%)

2 (1.5%)

6 (4.2%)

2 (1.5%)

 Appearance of a sign of critical illness

2 (1.4%)

2 (1.5%)

2 (1.4%)

3 (2.2%)

 Appearance of a new sign of serious infection

1 (0.7%)

2 (1.5%)

2 (1.4%)

0

 SAE other than death

0

0

0

0

 Hospitalization

0

0

0

0

 No improvement in clinical condition by day 4

10 (6.8%)

6 (4.4%)

1 (0.7%)

4 (3.0%)

 Reappearance of inclusion sign between days 5–8

2 (1.4%)

1 (0.7%)

2 (1.4%)

0

 Presence of inclusion sign on day 8

1 (0.7%)

0

0

0

  1. aRegimen A: IM Gentamicin and IM Penicillin × 7 days; Regimen B: IM Gentamicin and oral amoxicillin × 7 days; Regimen C: IM Gentamicin × 7 days and IM Penicillin × 2 days then oral amoxicillin × 5 days; Regimen D: IM Gentamicin × 2 days and oral amoxicillin × 7 days